Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Condition: Human Papillomavirus-Related Carcinoma Interventions: Procedure: Biospecimen Collection; Biological: HPV16 RG1 VLP Vaccine; Other: Questionnaire Administration; Biological: Recombinant Human Papillomavirus Nonavalent Vaccine; Other: Saline Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Carcinoma | Cervical Cancer Vaccine | Genital Warts | HPV Testing | Human Papillomavirus (HPV) | Research | Vaccines